Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
Aveline Filliol, Yoshinobu Saito, Ajay Nair, et al.
Nature (2022) Vol. 610, Iss. 7931, pp. 356-365
Open Access | Times Cited: 172

Showing 1-25 of 172 citing articles:

Hepatic inflammatory responses in liver fibrosis
Linda Hammerich, Frank Tacke
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 633-646
Closed Access | Times Cited: 246
Activated fibroblasts in cancer: Perspectives and challenges
Giuseppina Caligiuri, David A. Tuveson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 434-449
Open Access | Times Cited: 129
Fibroblast and myofibroblast activation in normal tissue repair and fibrosis
Fereshteh S. Younesi, Andrew Miller, Thomas H. Barker, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 8, pp. 617-638
Closed Access | Times Cited: 82
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 81
Advances in single-cell RNA sequencing and its applications in cancer research
Dezhi Huang, Naya Ma, Xinlei Li, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 70
Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies
Isabella Lurje, Nadine T. Gaisa, Ralf Weiskirchen, et al.
Molecular Aspects of Medicine (2023) Vol. 92, pp. 101191-101191
Closed Access | Times Cited: 58
Immunology of human fibrosis
Mallar Bhattacharya, Prakash Ramachandran
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1423-1433
Closed Access | Times Cited: 48
Friend or foe? The elusive role of hepatic stellate cells in liver cancer
Bruno Cogliati, Chittampalli Yashaswini, Shuang Wang, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 647-661
Open Access | Times Cited: 44
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 44
Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis
Kuo Du, Raquel Maeso‐Díaz, Seh Hoon Oh, et al.
Hepatology (2023) Vol. 77, Iss. 6, pp. 1998-2015
Open Access | Times Cited: 41
The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability
Arya Mariam Roy, Renuka Iyer, Sayan Chakraborty
Cell Reports Medicine (2023) Vol. 4, Iss. 9, pp. 101170-101170
Open Access | Times Cited: 37
Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
Ziyi Li, Rhea Pai, Saurabh Gupta, et al.
Nature Cancer (2024) Vol. 5, Iss. 1, pp. 167-186
Open Access | Times Cited: 29
Molecular mechanisms in MASLD/MASH-related HCC
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 29
Multimodal decoding of human liver regeneration
K P Matchett, John R. Wilson‐Kanamori, Jordan R. Portman, et al.
Nature (2024) Vol. 630, Iss. 8015, pp. 158-165
Open Access | Times Cited: 24
Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer
Fuming Li, Pingyu Liu, Mi Wen, et al.
Nature Cancer (2024) Vol. 5, Iss. 1, pp. 131-146
Open Access | Times Cited: 18
Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis
Thomas Savage, Katherine T. Fortson, Kenia de los Santos-Alexis, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 303-318.e6
Closed Access | Times Cited: 16
Inflammation‐Responsive Cell Membrane‐Camouflaged Nanoparticles against Liver Fibrosis via Regulating Endoplasmic Reticulum Stress and Oxidative Stress
Yang Bai, Jiaqi Chen, Sitong Zhang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Closed Access | Times Cited: 13
Ketocyanine‐Based Fluorescent Probe Revealing the Polarity Heterogeneity of Lipid Droplets and Enabling Accurate Diagnosis of Hepatocellular Carcinoma
Deming He, Minmin Yan, Qiuling Sun, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 7
Closed Access | Times Cited: 12
Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
Scott L. Friedman
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 2, pp. 161-169
Open Access | Times Cited: 12
Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer
Meirion Raymant, Yuliana Astuti, Laura Álvaro‐Espinosa, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
FBP1 controls liver cancer evolution from senescent MASH hepatocytes
Li Gu, Yahui Zhu, Shuvro P. Nandi, et al.
Nature (2025) Vol. 637, Iss. 8045, pp. 461-469
Closed Access | Times Cited: 2
Emerging role of aging in the progression of NAFLD to HCC
Yongyuan He, Yinghong Su, Chengcheng Duan, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101833-101833
Closed Access | Times Cited: 43
Increased cell senescence in human metabolic disorders
Rosa Spinelli, Ritesh K. Baboota, Silvia Gogg, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 35
Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma
Liren Zhang, Jiali Xu, Suiqing Zhou, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 1, pp. 82-98
Closed Access | Times Cited: 33
A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23
Yoshinobu Saito, Dingzi Yin, Naoto Kubota, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1279-1292
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top